About This Comparison
Our Editorial Standards
This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Best Wegovy Online (9 Compared)
Wegovy is a semaglutide injection specifically indicated for weight management in adults with obesity or overweight with weight-related conditions. It contains the same active ingredient as Ozempic but is dosed specifically for weight loss. Telehealth platforms now offer Wegovy with online consultations and home delivery.
What Is Wegovy and How Does It Work?
- FDA-approved semaglutide 2.4 mg for chronic weight management
- Weekly subcutaneous injection targeting appetite regulation
- GLP-1 receptor agonist mimicking natural satiety hormones
- Available through telehealth at various price points
STEP Trial Results: What the Research Shows
- STEP 1: 14.9% average weight loss over 68 weeks in 1,961 patients
- 86.4% achieved clinically meaningful 5% or more weight loss
- STEP 5: sustained 15.2% loss over 2 years of treatment
- Cardiovascular and metabolic markers also improved
How Wegovy Compares to Other Weight Loss Medications
- Produces more than double the weight loss of Saxenda (liraglutide)
- Tirzepatide (Zepbound) may produce greater average weight loss
- Both Wegovy and Zepbound are weekly injections
- Your provider helps determine the best option for you
Wegovy vs Compounded Semaglutide: Cost and Access
- Wegovy costs ,300 to ,400 per month without insurance
- Compounded semaglutide available at to monthly
- Both contain the same active ingredient at the same doses
- Some insurance plans now cover Wegovy with prior authorization
Wegovy Dosing Schedule and What to Expect
- Starts at 0.25 mg with increases every 4 weeks to 2.4 mg
- Full therapeutic dose reached by week 16
- Over 84% of trial participants tolerated the full dose
- Appetite reduction typically noticed within 1 to 2 weeks
Who Qualifies for Wegovy Treatment Online?
- BMI of 30 or higher typically qualifies
- BMI of 27 or higher with weight-related conditions may qualify
- Thyroid cancer history is a contraindication
- Virtual consultation with licensed provider required
Managing Wegovy Side Effects
- Nausea is most common at 33 to 44% but typically improves
- Discontinuation due to side effects only 2 to 7% in trials
- Side effects peak during dose escalation then decrease
- Report severe abdominal pain or persistent vomiting immediately
How to Get Wegovy Through Telehealth
- Complete an online health assessment in 10 to 15 minutes
- Licensed provider reviews your information and consults
- Medication shipped directly to your home
- Regular follow-ups included to track progress
Long-Term Weight Management with Wegovy
- STEP 4 showed weight regain after stopping treatment
- STEP 5 confirmed sustained results over 2 years
- Building sustainable habits during treatment is critical
- Your provider helps create a long-term plan
Choosing the Right Wegovy Provider
- Compare total program costs, not just medication price
- Look for complete medical oversight and follow-ups
- Verify pharmacy licensing and medication sourcing
- Consider additional services like nutrition coaching
Frequently Asked Questions
How much does Wegovy cost through telehealth in 2026?
Wegovy costs $199 for each of the first two monthly fills through manufacturer savings programs, then $349 per month for continued treatment. Without savings programs, list price is approximately $1300 per month. Insurance coverage varies by plan. Some telehealth platforms also offer compounded semaglutide at lower prices as an alternative.
How much weight can I expect to lose on Wegovy?
Clinical trials showed average weight loss of approximately 15 percent of body weight, or about 35 pounds, over 68 weeks. About 77 percent of patients lost 10 percent or more of their body weight. Individual results vary based on starting weight, adherence, diet, exercise, and other factors.
What is the difference between Wegovy and Ozempic?
Wegovy and Ozempic both contain semaglutide. Wegovy is specifically indicated for weight management and follows a dosing schedule up to 2.4 mg weekly. Ozempic is indicated for type 2 diabetes, though sometimes prescribed off-label for weight loss. Wegovy dosing was specifically tested for weight management in clinical trials.
Do I need a prescription for Wegovy?
Yes, Wegovy requires a prescription from a licensed healthcare provider. Telehealth platforms connect you with licensed doctors or nurse practitioners who evaluate your eligibility based on BMI and health history. To qualify, you typically need BMI of 30 or higher, or BMI of 27 or higher with weight-related conditions.
How long does it take to see results with Wegovy?
Most people notice reduced appetite within one to two weeks. Visible weight loss typically becomes apparent after two to three months at therapeutic doses. Maximum results are usually achieved at 12 to 18 months of continued treatment. Patience is important as dosing increases gradually over the first four to five months.
What are common side effects of Wegovy?
Common side effects include nausea, constipation, diarrhea, decreased appetite, and occasionally vomiting. These are usually most noticeable when starting or increasing doses, and typically improve within a few weeks. Serious side effects are rare but can include pancreatitis, gallbladder problems, and allergic reactions.
Will I gain weight back after stopping Wegovy?
Some weight regain is possible after stopping Wegovy, as clinical trials showed some weight return after discontinuing treatment. Maintaining weight loss requires ongoing healthy eating and regular physical activity. Some people choose to continue treatment long term for weight maintenance, while others use it to achieve initial weight loss then maintain with lifestyle changes.
Can I use Wegovy if I have diabetes?
Yes, Wegovy can be used by people with type 2 diabetes. The medication helps with both weight loss and blood sugar control. If you have diabetes, your provider may need to adjust other diabetes medications while you are on Wegovy to avoid low blood sugar.
Does insurance cover Wegovy for weight loss?
Insurance coverage for Wegovy varies significantly by plan. Some insurers cover it for weight management, especially with weight-related health conditions. Others do not cover weight loss medications. Your telehealth provider can help verify your coverage and access manufacturer savings programs if insurance does not cover it.
Which telehealth platform is best for Wegovy?
The best platform depends on your needs. Ro, Found, and Calibrate offer complete weight management programs with Wegovy access and coaching support. WeightWatchers and Lemonaid Health provide straightforward prescription services. Consider program features, cost, insurance acceptance, provider support, and customer reviews when choosing.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
- Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in adults with BMI of 30 or higher, or 27 or higher with at least one weight-related comorbidity
- In real-world settings, semaglutide treatment outcomes match the results seen in controlled clinical trials
- In STEP 1, 1,961 adults without diabetes lost an average of 14.9% body weight over 68 weeks on semaglutide 2.4 mg compared to 2.4% on placebo
- Real-world data comparing 18,386 patients showed tirzepatide (Zepbound/Mounjaro) produced 15.3% weight loss at 12 months versus 8.3% for semaglutide
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards